These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 28403893)

  • 1. Approaches to interpreting and choosing the best treatments in network meta-analyses.
    Mbuagbaw L; Rochwerg B; Jaeschke R; Heels-Andsell D; Alhazzani W; Thabane L; Guyatt GH
    Syst Rev; 2017 Apr; 6(1):79. PubMed ID: 28403893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The rank-heat plot is a novel way to present the results from a network meta-analysis including multiple outcomes.
    Veroniki AA; Straus SE; Fyraridis A; Tricco AC
    J Clin Epidemiol; 2016 Aug; 76():193-9. PubMed ID: 26939929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ranking treatments in frequentist network meta-analysis works without resampling methods.
    Rücker G; Schwarzer G
    BMC Med Res Methodol; 2015 Jul; 15():58. PubMed ID: 26227148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1.
    Jansen JP; Fleurence R; Devine B; Itzler R; Barrett A; Hawkins N; Lee K; Boersma C; Annemans L; Cappelleri JC
    Value Health; 2011 Jun; 14(4):417-28. PubMed ID: 21669366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of reporting bias in network meta-analysis of antidepressant placebo-controlled trials.
    Trinquart L; Abbé A; Ravaud P
    PLoS One; 2012; 7(4):e35219. PubMed ID: 22536359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical evaluation of SUCRA-based treatment ranks in network meta-analysis: quantifying robustness using Cohen's kappa.
    Daly CH; Neupane B; Beyene J; Thabane L; Straus SE; Hamid JS
    BMJ Open; 2019 Sep; 9(9):e024625. PubMed ID: 31492773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Normalized Entropy to Measure Uncertainty of Rankings for Network Meta-analyses.
    Wu YC; Shih MC; Tu YK
    Med Decis Making; 2021 Aug; 41(6):706-713. PubMed ID: 33754893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bibliographic study showed improving statistical methodology of network meta-analyses published between 1999 and 2015.
    Petropoulou M; Nikolakopoulou A; Veroniki AA; Rios P; Vafaei A; Zarin W; Giannatsi M; Sullivan S; Tricco AC; Chaimani A; Egger M; Salanti G
    J Clin Epidemiol; 2017 Feb; 82():20-28. PubMed ID: 27864068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Bae SC; Song GG
    Rheumatol Int; 2015 Dec; 35(12):1965-74. PubMed ID: 25994093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncertainty in Treatment Rankings: Reanalysis of Network Meta-analyses of Randomized Trials.
    Trinquart L; Attiche N; Bafeta A; Porcher R; Ravaud P
    Ann Intern Med; 2016 May; 164(10):666-73. PubMed ID: 27089537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overlapping network meta-analyses on the same topic: survey of published studies.
    Naudet F; Schuit E; Ioannidis JPA
    Int J Epidemiol; 2017 Dec; 46(6):1999-2008. PubMed ID: 29040566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network Meta-Analysis.
    Watt J; Del Giovane C
    Methods Mol Biol; 2022; 2345():187-201. PubMed ID: 34550592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What guidance are researchers given on how to present network meta-analyses to end-users such as policymakers and clinicians? A systematic review.
    Sullivan SM; Coyle D; Wells G
    PLoS One; 2014; 9(12):e113277. PubMed ID: 25517510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying and presenting overall evidence in network meta-analysis.
    Lin L
    Stat Med; 2018 Dec; 37(28):4114-4125. PubMed ID: 30019428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2.
    Hoaglin DC; Hawkins N; Jansen JP; Scott DA; Itzler R; Cappelleri JC; Boersma C; Thompson D; Larholt KM; Diaz M; Barrett A
    Value Health; 2011 Jun; 14(4):429-37. PubMed ID: 21669367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and cyclophosphamide as induction therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Song GG
    Lupus; 2015 Dec; 24(14):1520-8. PubMed ID: 26162684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and safety of tocilizumab, rituximab, abatacept and tofacitinib in patients with active rheumatoid arthritis that inadequately responds to tumor necrosis factor inhibitors: a Bayesian network meta-analysis of randomized controlled trials.
    Lee YH; Bae SC
    Int J Rheum Dis; 2016 Nov; 19(11):1103-1111. PubMed ID: 26692536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Graphical exploration of network meta-analysis data: the use of multidimensional scaling.
    Chung H; Lumley T
    Clin Trials; 2008; 5(4):301-7. PubMed ID: 18697844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the need for increased rigour and care in the conduct and interpretation of network meta-analyses in drug development.
    Carroll K; Hemmings R
    Pharm Stat; 2016; 15(2):135-42. PubMed ID: 26732132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borrowing of strength from indirect evidence in 40 network meta-analyses.
    Lin L; Xing A; Kofler MJ; Murad MH
    J Clin Epidemiol; 2019 Feb; 106():41-49. PubMed ID: 30342086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.